COVID-19, Rheumatic Diseases and Immunosuppressive Drugs: An Appeal For Medication Adherence

Rheumatology International 2020

Yun-Jung Kang

Dear Editor,

The novel coronavirus (SARS-CoV-2) outbreak has raised concerns among patients on chronic immunosuppressive therapy because of immune response to virus perceived to be lowered, possibly fuelling non-adherence behaviour. Indeed, high frequency of infection has been observed in patients with rheumatic diseases. Despite immunosuppressive agents and impaired immune function had been associated with increased risk of infection, it must be remembered that uncontrolled disease activity is among the most sensitive and specific independent predictors.

Keywords

Clinical Aspects, Diagnosis, Treatment